NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Hyporesponsiveness of Polymorphonuclear Cells after In Vivo Exposure of Normal Humans to Endotoxin.

SCHULTZ MJ, DE JONGE E, DEKKERS PE, VAN DEVENTER SJ, VAN DER POLL T; Interscience Conference on Antimicrobial Agents and Chemotherapy.

Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother. 1999 Sep 26-29; 39: 371 (abstract no. 499).

Academic Med. Ctr., Dept. of Intensive Care Med., Lab. of Experimental Internal Med., Amsterdam, NETHERLANDS

INTRODUCTION: Polymorphonuclear cells (PMNs) and mononuclear cells play a key role in inflammatory processes and during the sepsis syndrome. Mononuclear cells have been found to be hyporesponsive after stimulation with endotoxin (lipopolysaccharide, LPS) in vivo, a phenomenon reffered to as LPS tolerance. The pro-inflammatory interleukin (IL-) 8 is produced by PMNs. Aim andMETHODS: To determine the influence of an intravenous injection of LPS on the capacity of PMNs to produce IL-8 upon restimulation with bacterial products ex vivo, PMNs were isolated from 6 healthy humans directly before and at various time points after a single dose of LPS (4 ng/kg). PMNs (approximately 10[6] PMN/ml) were incubated for 24 hours at 37[0]C with 10[7] CFU/ml heat-killed Streptococcus pneumonia (HKSP), 10[7] CFU/ml heat-killed Pseudomonas aeruginosa (HKPA) and 10 ng/ml E. coli LPS. IL-8 levels were measured in supernatant (ELISA). In a separate series of experiments, PMNs from 6 other healthy volunteers (who did not receive LPS) were incubated as described above in the presence of increasing concentrations of pooled serum obtained from the LPS-challenged volunteers before (pre-LPS serum) and at various intervals after in vivo administration of LPS (post-LPS serum). Data are means +/- SE, statistics by Wilcoxon.RESULTS: The capacity of PMNs to produce IL-8 upon restimulation with HKSP, HKPA and LPS strongly decreased after in vivo exposure to LPS (production before intravenous LPS: 23.2 +/- 10.5, 2.4 +/- 0.7 and 1.8 +/- 1.4 ng/10[6] PMN, respectively; maximal inhibition to 1.7 +/- 0.3, 0.4 +/- 0.1 and 0.1 +/- 0.0 ng/10[6] PMN at 1 hour after in vivo LPS injection, respectively [all P < .05]). Production returned to normal after 24 hours. Further experiments with pooled serum demonstrated that IL-8 production by PMNs from healthy volunteers not receiving LPS, was not suppressed in the presence of increasing concentrations (0-20%) of post-LPS serum compared with pre-LPS serum.CONCLUSION: PMNs are hyporesponsive after in vivo exposure to LPS; this is not due to soluble factors produced after intravenous injection of LPS.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Accidents
  • Animals
  • Endotoxins
  • Humans
  • Immune Tolerance
  • Interleukin-8
  • Lipopolysaccharides
  • Neutrophils
  • Pseudomonas aeruginosa
  • Systemic Inflammatory Response Syndrome
  • immunology
  • injuries
Other ID:
  • GWAIDS0007993
UI: 102245490

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov